Anzeige
+++Geheime Kupferaktie: Kupfer auf Rekordhoch – steht dieser geheime Junior-Explorer jetzt vor einer Neubewertung?+++
PortfolioPlus
Dein Depot in Echtzeit – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
EQS-News

Carolindica Expands Wellness Portfolio With Launch of High-potency CBD and Minor Cannabinoid Gummies and Capsules 19.08.2026, 14:11 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Carolindica / Key word(s): Science
Carolindica Expands Wellness Portfolio With Launch of High-potency CBD and Minor Cannabinoid Gummies and Capsules

19.08.2026 / 14:11 CET/CEST
The issuer is solely responsible for the content of this announcement.


New Collection Features Targeted Daytime, Nighttime and Broad-spectrum Wellness Formulations Designed to Meet a Variety of Consumer Needs

RALEIGH, NORTH CAROLINA - August 19, 2026 (NEWMEDIAWIRE) - Carolindica, a leading North Carolina hemp manufacturer and retailer, today announced the launch of its newest collection wellness products, introducing multiple high-potency CBD, CBG and minor cannabinoid formulations in both gummy and capsule formats.

The expanded lineup is designed to provide consumers with targeted wellness options for everyday support, focus and relaxation while continuing Carolindica's commitment to quality ingredients, transparent manufacturing and hemp products made to the highest standards.

The new collection includes:

  • 250mg Broad Spectrum CBD Gummies: available in 10-count and 25-count packages.

  • 250mg Broad Spectrum CBG Gummies available in 10-count and 25-count packages.

  • Extra Strength Sandman Gummies, featuring 50mg CBD and 50mg CBN in a full-spectrum formulation designed for evening wellness.

  • Extra Strength Sunrise Gummies, featuring a full-spectrum blend of 45mg CBD, 45mg CBG and 10mg CBC to support daytime balance.

  • Extra Strength Sunrise Capsules, delivering the same CBD, CBG and CBC formulation in an easy-to-take capsule available in multiple package sizes.

"Consumers today are becoming much more educated about cannabinoids beyond CBD," said Chris Karazin, Carolindica CEO. "Our newest product line reflects that evolution by offering purpose-built formulations that combine cannabinoids like CBG, CBC and CBN to leverage the entourage effect they have when combined as well as to offer customers products that align with their individual wellness goals."

Unlike traditional CBD products that focus on a single cannabinoid, Carolindica's newest offerings incorporate carefully selected cannabinoid profiles to provide options for consumers seeking daytime support, nighttime relaxation or broad-spectrum wellness without compromising on quality or value.

Each product is manufactured using premium hemp-derived ingredients and undergoes rigorous third-party lab testing to ensure potency, purity and consistency. The new lineup builds upon Carolindica's growing portfolio of wellness products available through its retail locations and online storefront.

The collection is available now at Carolindica retail stores and online at www.carolindica.com

About Carolindica

Carolindica is a North Carolina-based hemp and wellness company dedicated to developing high-quality, plant-based products that support everyday wellbeing. Its portfolio includes premium hemp-derived cannabinoid products as well as the Evoke wellness line of botanical supplements designed to support everyday health and vitality. With a focus on formulation integrity, transparency and innovation, Carolindica delivers trusted solutions across cannabinoid and non-cannabinoid wellness categories. Learn more at https://carolindica.com/.

Contact:
Kyle Porter
carolindica@virgo-pr.com

View the original release on www.newmediawire.com


News Source: Carolindica


19.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Carolindica
United States
EQS News ID: 2385768

 
End of News EQS News Service

2385768  19.08.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
Werbung

Ihre Lieblingsaktie geschenkt

BörsenNEWS.de und Smartbroker+ starten gemeinsam eine exklusive Bonus-Aktion. Eröffnen Sie bis 31.08.2026 ein Depot bei Smartbroker+ und erhalten als Willkommensgeschenk einen Anteil ausgewählter Aktien im Wert von 50 Euro!.

k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer